Valuation: Illumina, Inc.

Market Cap 28.32B 24.76B 22.84B 20.99B 39.78B 2,725B 40.46B 273B 107B 1,332B 106B 104B 4,590B P/E 2026 *
39.9x
P/E 2027 * 32.9x
Enterprise Value 28.84B 25.21B 23.26B 21.38B 40.51B 2,775B 41.2B 278B 109B 1,356B 108B 106B 4,675B EV / Sales 2026 *
6.31x
EV / Sales 2027 * 5.83x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day-2.12%
1 week-2.40%
Current month+6.44%
1 month+16.26%
3 months+43.61%
6 months+29.99%
Current year+42.69%
1 week 184.02
Extreme 184.02
195.97
1 month 157.63
Extreme 157.63
196.66
Current year 112.65
Extreme 112.65
196.66
1 year 88
Extreme 88
196.66
3 years 68.7
Extreme 68.7
196.66
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
06-30Free

Director

167 0.0001%
06-30
Corvex Management LP
OtherCompany 0 0%
06-30Free

Director

142 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.12%-2.40%+89.94%0.00% 28.93B
+0.23%+3.61%+25.85%+1.12% 198B
+2.50%-8.97%-24.68%+9.88% 134B
+0.87%+3.40%+1.54%-16.52% 141B
+0.96%-4.99%-58.75%-18.84% 63.36B
-3.13%-7.96%+11.48%-6.54% 51.87B
+1.34%-1.42%-24.44%-32.76% 43.77B
-0.36%+2.72%+12.18%+12.49% 38.18B
-0.39%-0.00%+23.26%+38.46% 36.96B
+2.50%-2.60%-15.11%-22.76% 28.05B
Average -0.51%-2.20%+4.13%-3.55% 76.49B
Weighted average by Cap. -0.21%-1.96%+1.75%-3.25%

Financials

2026 *2027 *
Net sales 4.57B 4B 3.69B 3.39B 6.42B 440B 6.53B 44.01B 17.27B 215B 17.16B 16.79B 741B 4.83B 4.22B 3.89B 3.58B 6.78B 464B 6.9B 46.47B 18.23B 227B 18.13B 17.73B 782B
Net income 723M 633M 583M 536M 1.02B 69.61B 1.03B 6.97B 2.73B 34.02B 2.72B 2.66B 117B 869M 760M 701M 644M 1.22B 83.61B 1.24B 8.37B 3.28B 40.86B 3.26B 3.19B 141B
Net Debt 522M 456M 421M 387M 733M 50.23B 746M 5.03B 1.97B 24.55B 1.96B 1.92B 84.61B -160M -140M -129M -118M -224M -15.37B -228M -1.54B -604M -7.51B -600M -587M -25.9B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
15/07/26 $187.15 -2.12% 1,781,235
14/07/26 $191.20 +0.61% 1,994,908
13/07/26 $190.05 -0.08% 1,198,925
10/07/26 $190.20 -1.84% 1,076,328
09/07/26 $193.76 +3.17% 1,725,053
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
187.15USD
Average target price
163.05USD
Spread / Average Target
-12.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock